Should parents be allowed to genetically edit their unborn children to remove hereditary diseases, even if it opens the door to cosmetic genetic selection?

Sonar Pro

Vote: Only for diseases

Option **B** strikes the optimal balance: permit germline editing strictly for eliminating hereditary diseases, maximizing health benefits while minimizing risks of misuse for cosmetic enhancements. Search results highlight substantial **safety risks** like off-target mutations, mosaicism, and heritable harms that could affect future generations, making unrestricted editing (A) premature—CRISPR is not yet safe for clinical use[1]. Yet, the potential to **prevent diseases** is a compelling benefit, supported by ethical arguments for procreative beneficence when targeting serious conditions[2][3]. A total ban (C) ignores these benefits and existing precedents like preimplantation genetic diagnosis, which already screen for diseases without controversy[1]. The 'slippery slope' to eugenics or designer babies is a valid concern[1][2], but enforceable regulations can confine it to therapeutic uses, as emphasized in calls for oversight[1][4]. This approach aligns with consensus: therapies on embryos are justifiable only for survival or integrity, not enhancements[2], preventing inequality and dignity violations while promoting good[1].

GPT-5.4

Vote: Only for diseases

Preventing serious hereditary disease is a strong and humane use of genetic editing. If the technology is safe and effective, using it to spare a child from predictable suffering, disability, or early death is ethically justified. But that does not require permitting cosmetic selection. Disease prevention has a clear medical purpose; selecting for appearance, height, or other nonmedical traits shifts from treatment to enhancement and invites inequality, social pressure, and modern eugenics. A total ban is too blunt because it blocks real medical benefit for families with devastating inherited conditions. The better approach is strict regulation: allow narrowly defined therapeutic edits, prohibit cosmetic uses, and enforce oversight, transparency, and penalties for abuse. In short, we should draw a firm line between curing disease and designing traits. That preserves compassion and medical progress without surrendering to a genetic marketplace.

Grok 4.1 Fast

Vote: Only for diseases

Allowing genetic editing only for hereditary diseases strikes a crucial ethical balance: it prevents needless suffering from conditions like cystic fibrosis or Huntington's, which affect millions, while prohibiting cosmetic enhancements that could lead to a dystopian 'designer baby' market. This targeted approach leverages proven technologies like CRISPR-Cas9, already FDA-approved for sickle cell anemia, ensuring medical benefits without opening the floodgates to inequality—wealthy parents selecting for height, intelligence, or eye color would widen social divides. A full ban (C) condemns future generations to preventable pain out of fear; unrestricted allowance (A) prioritizes autonomy over safeguards, risking eugenics-like abuses. Strict regulation for diseases only is feasible, as seen in IVF screening laws, making B the responsible path forward.

Kimi K2.5

Vote: Only for diseases

We must draw a clear ethical line between healing and enhancement. Allowing parents to eliminate hereditary diseases like cystic fibrosis or Huntington's prevents immense suffering and respects the child's right to health. This is fundamentally a medical intervention, morally equivalent to prenatal surgery or vaccination. However, opening the door to cosmetic selection—choosing height, eye color, or intelligence—creates profound societal harms. It would exacerbate inequality by creating genetic 'haves' and 'have-nots,' reduce human genetic diversity, and transform reproduction into a consumer market where children become products designed to parental specifications. We can effectively regulate this distinction. Just as we distinguish between medically necessary procedures and cosmetic surgery in existing healthcare frameworks, we can permit somatic editing for serious pathogenic variants while prohibiting germline modifications for non-medical traits. This balances compassion for the sick against the risks of genetic stratification. A total ban denies relief to families facing devastating genetic conditions, while unrestricted access commodifies human life. The 'medical only' approach is the only framework that honors both human dignity and scientific progress.

Claude Opus 4.6

Vote: Only for diseases

Genetic editing to remove serious hereditary diseases like Huntington's, cystic fibrosis, or sickle cell anemia represents one of the most profound medical advances in human history. Denying families access to this technology when it could prevent immense suffering would be ethically unjustifiable — akin to banning vaccines or surgery. However, allowing unrestricted cosmetic genetic selection (eye color, height, intelligence enhancement) raises serious concerns about exacerbating social inequality, reducing genetic diversity, and commodifying children. A world where wealthy parents can purchase 'designer babies' while others cannot would deepen existing class divides in dangerous ways. Option B strikes the right balance. We can establish clear regulatory frameworks — similar to how we regulate organ transplantation or experimental therapies — that permit genetic editing for well-defined, serious medical conditions while prohibiting cosmetic or enhancement modifications. Medical ethics boards and regulatory agencies already make these kinds of distinctions routinely. The slippery slope argument (that allowing disease editing inevitably leads to cosmetic selection) is not compelling enough to justify a total ban. We don't ban kitchen knives because they could be used as weapons. We regulate. Many countries already have functional regulatory frameworks for embryo selection through IVF/PGD that draw exactly this line between medical necessity and enhancement. Banning it entirely (Option C) would condemn children to preventable suffering. Allowing everything (Option A) invites dystopian inequality. Option B is the principled, pragmatic middle ground.

Gemini 3.1 Pro

Vote: Only for diseases

Allowing genetic editing to eradicate severe hereditary diseases has the potential to eliminate immense human suffering and prevent fatal conditions before they begin. Denying a life-saving medical intervention simply out of fear of a 'slippery slope' toward cosmetic editing is unethical and stifles crucial medical progress. However, opening the floodgates to cosmetic genetic selection risks creating severe societal inequalities and dystopian 'designer baby' scenarios. We must not allow genetics to become a luxury commodity that divides society. The solution lies in strict, globally enforced regulatory frameworks. By legally restricting genetic editing strictly to verified medical necessities and hereditary diseases, we can safely harness the therapeutic benefits of the technology while definitively closing the door on cosmetic enhancements.

Final Summary

The AI Roundtable reached a swift and unanimous consensus, firmly rejecting both total bans and unregulated genetic selection in favor of a strictly therapeutic middle ground. Models like Claude Opus 4.6 and Kimi K2.5 argued that denying medical intervention for devastating diseases is ethically unjustifiable, while GPT-5.4 and Gemini 3.1 Pro warned that moving into cosmetic enhancement would transform children into consumer products and exacerbate social inequality.

All 6 models agreed on "Only for diseases" after discussion

Strongest Arguments

• Only for diseases: Claude Opus 4.6 dismantled the 'slippery slope' argument by noting that we do not ban kitchen knives simply because they could be used as weapons; instead, we regulate them, just as we can regulate genetic editing to permit healing while prohibiting enhancement.